Recent Quotes (30 days)

You have no recent quotes
chg | %

The Biotech Growth Trust Plc  

(Public, LON:BIOG)   Watch this stock  
476.75
-9.75 (-2.00%)
Jul 28 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 476.36 - 492.64
52 week 388.00 - 557.00
Open 488.50
Vol / Avg. 121,461.00/123,936.00
Mkt cap 321.62M*
P/E 3.76
Div/yield     -
EPS 1.27*
Shares 67.46M
Beta     -
Inst. own     -
*GBP

Key stats and ratios

Q1 (Mar '14) 2014
Net profit margin 90.75% 95.76%
Operating margin 90.86% 95.87%
EBITD margin - 95.87%
Return on average assets 23.03% 26.68%
Return on average equity 25.39% 29.78%
CDP Score - -

Address

25 Southampton Buildings
LONDON, ENG WC2A 1AL
United Kingdom - Map
+44-20-74264000 (Phone)
+44-20-72474722 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

The Biotech Growth Trust PLC seeks capital appreciation through investment in the worldwide biotechnology industry, principally by investing in emerging biotechnology companies. The Company invests in a diversified portfolio of biotechnology (including emerging biotechnology companies) and related securities on a worldwide basis. The Company�s top 10 investments included Warner Chilcott, Impax Laboratories, Actelion, Onyx Pharmaceutical, Affymetrix, Regeneron Pharmaceutical, 3SBio, Immunogen, Cubist Pharmaceutical and Neurocrine Biosciences. The Company�s Investment Manage is OrbiMed Capital LLC.